Vivian Chow
  1. Associate

Ms. Chow is an associate in Davis Polk’s Corporate Department, resident in Hong Kong.

Work Highlights

  • Ocumension Therapeutics’ $200.4 million Hong Kong IPO and global offering
  • Innovent Biologics’ $403.1 million Hong Kong IPO and global offering
  • AsiaInfo Technologies' $110.6 million Hong Kong IPO and global offering
  • China Everbright Greentech’s $390.2 million Hong Kong IPO and global offering
  • Innovent Biologics’ HK$2.4 billion top-up placing and HK$2.4 billion primary placing
  • Hong Kong Television Network’s HK$464 million top-up placing
  • Tencent Music Entertainment Group's $800 million notes offering
  • Tencent’s $6 billion senior notes offering under its global MTN program
  • CITIC Securities’ $3 Billion MTN program update and $800 million drawdown notes offering
  • Mongolian Mining Corporation’s tender offers, consent solicitation and $440 million high-yield notes offering
  • Chalco’s $500 million senior perpetual capital securities offering
  • Fosun International's $500 million notes offering
  • Hong Yang Group’s debut $250 million high-yield notes offering
  • EF Education First on the proposed majority investment by Permira in EF Kids & Teens business
  • Vanke Services on the formation of a joint venture with Cushman & Wakefield
  • Comcast’s T1 esports joint venture with SK Telecom
Pro Bono
  • Reviewing contract documents and providing related advice for a non-profit arts and culture organization
  • Advising a non-profit international development organization on one of the first “pay for success” projects in Hong Kong

Professional History

  • Davis Polk since 2016

Practice Focus

Bar Admissions

  • Hong Kong
  • State of New York


  • B.A., Law, University of Cambridge, 2015
  • M.A., University of Cambridge, 2019